SPONSOR
Cure HHT
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Hereditary Hemorrhagic TelangiectasiaArteriovenous MalformationsTelangiectasiaEpistaxisGastroIntestinal BleedingCerebral Arteriovenous MalformationsVascular Malformation
Cure HHT is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia, Epistaxis.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Cure HHT
How many clinical trials has Cure HHT sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Cure HHT, of which 1 are actively recruiting participants. These trials cover conditions including Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cure HHT research focus on?
Cure HHT clinical trials span Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia, Epistaxis, GastroIntestinal Bleeding, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Cure HHT clinical trial?
To participate in a Cure HHT trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cure HHT trials with current recruitment status updated daily.
Clinical Trials by Cure HHT
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology